AquaBounty Technologies Inc AQB:NASDAQ

Last Price$2.36NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$2.36 (5)
Ask (Size)$2.50 (3)
Day Low / HighN/A - N/A
Volume1.2 M

View Biotechnology IndustryPeer Comparison as of 12/03/2021


AquaBounty Technologies Inc ( NASDAQ )

Price: $2.36
Change: -0.21 (8.17%)
Volume: 1.2 M
4:00PM ET 12/03/2021

Seelos Therapeutics Inc ( NASDAQ )

Price: $1.64
Change: -0.10 (5.75%)
Volume: 5.5 M
4:00PM ET 12/03/2021

Infinity Pharmaceuticals Inc ( NASDAQ )

Price: $1.86
Change: -0.16 (7.92%)
Volume: 2.0 M
4:00PM ET 12/03/2021

Larimar Therapeutics Inc ( NASDAQ )

Price: $9.59
Change: +0.01 (0.10%)
Volume: 76.7 K
4:00PM ET 12/03/2021

Ardelyx Inc ( NASDAQ )

Price: $1.52
Change: -0.18 (10.59%)
Volume: 146.6 M
4:00PM ET 12/03/2021

Read more news Recent News

Insider Sell: Aquabounty Technologies
7:34AM ET 11/26/2021 MT Newswires

Randal J Kirk, 10% Owner, on November 23, 2021, sold 12,880,000 shares in Aquabounty Technologies (AQB) for $27,048,000. Following the Form 4 filing with...

Insider Sell: Aquabounty Technologies
7:33AM ET 11/26/2021 MT Newswires

Alana Kirk, 10% Owner, Director, on November 23, 2021, sold 12,880,000 shares in Aquabounty Technologies (AQB) for $27,048,000. Following the Form 4 filing...

Sector Update: Consumer Stocks Ending Mixed This Afternoon
3:51PM ET 11/19/2021 MT Newswires

Consumer stocks were mixed in Friday trading, with the SPDR Consumer Staples Select Sector ETF (XLP) slipping 0.3% while the SPDR Consumer Discretionary...

Top Midday Decliners
2:04PM ET 11/19/2021 MT Newswires

Flora Growth (FLGC) said it priced an underwritten public offering of 10 million units at $3 apiece, with each unit comprising one common share and...

Company Profile

Business DescriptionAquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. It includes farming of aquatic organisms such as fish, shellfish, crustaceans, and aquatic plants. The firm focuses on salmon product, a bioengineered Atlantic salmon that can grow to market size faster than conventional farmed Atlantic salmon. The company was founded by Elliot Z. Entis and Garth L. Fletcher on December 17, 1991 and is headquartered in Maynard, MA. View company web site for more details
Address2 Mill & Main Place
Maynard, Massachusetts 01754
Number of Employees39
Recent SEC Filing11/24/2021SC 13D/A
President, Chief Executive Officer & DirectorSylvia A. Wulf
Chief Operating OfficerAlejandro Rojas
Chief Financial Officer & TreasurerDavid A. Frank
Chief Technology OfficerMark Walton

Company Highlights

Price Open$2.58
Previous Close$2.57
52 Week Range$2.32 - 13.32
Market Capitalization$167.6 M
Shares Outstanding71.0 M
SectorHealth Technology
Next Earnings Announcement03/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.36
Beta vs. S&P 500N/A
Revenue$84.5 K
Net Profit Margin-2,770.93%
Return on Equity-11.28%

Analyst Ratings as of 11/08/2021

Consensus RecommendationConsensus Icon
Powered by Factset